Difficult transmembrane protein targets for therapeutic antibodies

FHS
July 12, 2023
6:48 am

In this interview, News-Medical talks to Sylvia Xie, product scientist at Sino Biological, about the ongoing emergence of transmembrane proteins as targets for therapeutic antibodies.

New inhibitor drug shows promise in preventing diabetic eye and kidney disease

New research has shown a new type of inhibitor drug could prevent microvascular diabetic complications, such as diabetic eye and kidney disease.

February 3, 2024

Congressman blames Trump team for ending telehealth Medicare benefit. That’s not quite right.

Rep. Ro Khanna (D-Calif.) posted a Tiktok video on Feb. 20 saying he had “breaking news” about the fate of Medicare coverage for telehealth visits,

March 17, 2025

BridgeBio’s $250M offering; ViiV’s PhI data for ultra-long-acting HIV treatment

Plus, news about Viking Therapeutics, Arcutis Biotherapeutics, Akari and Peak Bio: BridgeBio’s stock sale: The company announced plans to raise $250 million the same day

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.